These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 24798975)

  • 1. Retinoic acid receptor-related receptor alpha (RORalpha) is a prognostic marker for hepatocellular carcinoma.
    Fu RD; Qiu CH; Chen HA; Zhang ZG; Lu MQ
    Tumour Biol; 2014 Aug; 35(8):7603-10. PubMed ID: 24798975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Integrator complex subunit 6 (INTS6) inhibits hepatocellular carcinoma growth by Wnt pathway and serve as a prognostic marker.
    Lui KY; Zhao H; Qiu C; Li C; Zhang Z; Peng H; Fu R; Chen HA; Lu MQ
    BMC Cancer; 2017 Sep; 17(1):644. PubMed ID: 28899352
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreased expression of ALDH1L1 is associated with a poor prognosis in hepatocellular carcinoma.
    Chen XQ; He JR; Wang HY
    Med Oncol; 2012 Sep; 29(3):1843-9. PubMed ID: 21987076
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuron-glial antigen 2 overexpression in hepatocellular carcinoma predicts poor prognosis.
    Lu LL; Sun J; Lai JJ; Jiang Y; Bai LH; Zhang LD
    World J Gastroenterol; 2015 Jun; 21(21):6649-59. PubMed ID: 26074703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A novel prognostic biomarker SPC24 up-regulated in hepatocellular carcinoma.
    Zhu P; Jin J; Liao Y; Li J; Yu XZ; Liao W; He S
    Oncotarget; 2015 Dec; 6(38):41383-97. PubMed ID: 26515591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prostate tumor overexpressed 1 is a novel prognostic marker for hepatocellular carcinoma progression and overall patient survival.
    Chen SP; Zhang LS; Fu BS; Zeng XC; Yi HM; Jiang N
    Medicine (Baltimore); 2015 Jan; 94(4):e423. PubMed ID: 25634174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Downregulation of betaine homocysteine methyltransferase (BHMT) in hepatocellular carcinoma associates with poor prognosis.
    Jin B; Gong Z; Yang N; Huang Z; Zeng S; Chen H; Hu S; Pan G
    Tumour Biol; 2016 May; 37(5):5911-7. PubMed ID: 26592251
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Down-regulation of the tumour suppressor κ-opioid receptor predicts poor prognosis in hepatocellular carcinoma patients.
    Chen D; Chen Y; Yan Y; Pan J; Xing W; Li Q; Zeng W
    BMC Cancer; 2017 Aug; 17(1):553. PubMed ID: 28821282
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of retinoic acid-induced protein 3 predicts poor prognosis for hepatocellular carcinoma.
    Zheng J; Guo X; Gao X; Liu H; Tu Y; Zhang Y
    Clin Transl Oncol; 2014 Jan; 16(1):57-63. PubMed ID: 23632812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-7 downregulates the oncogene VDAC1 to influence hepatocellular carcinoma proliferation and metastasis.
    Wang F; Qiang Y; Zhu L; Jiang Y; Wang Y; Shao X; Yin L; Chen J; Chen Z
    Tumour Biol; 2016 Aug; 37(8):10235-46. PubMed ID: 26831666
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High expression of inositol polyphosphate phosphatase-like 1 associates with unfavorable survival in hepatocellular carcinoma.
    Fu M; Gu X; Ni H; Zhang W; Chang F; Gong L; Chen X; Li J; Qiu L; Shi C; Bao J
    Int J Clin Exp Pathol; 2013; 6(11):2515-22. PubMed ID: 24228114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High expression of myofibrillogenesis regulator-1 predicts poor prognosis for patients with hepatocellular carcinoma after curative hepatectomy.
    Wang C; Xiang H; Si H; Guo D; Sun M
    Int J Clin Exp Pathol; 2015; 8(11):14818-23. PubMed ID: 26823810
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DLX4 as a prognostic marker for hepatocellular carcinoma.
    Gao Y; Li Z; Guo X; Liu Y; Zhang K
    Neoplasma; 2014; 61(3):318-23. PubMed ID: 24824934
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Downregulation of LHPP Expression Associated with AFP Acts as a Good Prognostic Factor in Human Hepatocellular Carcinoma.
    Chao X; Zhang W; Wu J; Feng X; Shi H; Zhao L; Shen H; Jiang C
    Biomed Res Int; 2021; 2021():1971048. PubMed ID: 34485511
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated DSN1 expression is associated with poor survival in patients with hepatocellular carcinoma.
    Sun C; Huang S; Ju W; Hou Y; Wang Z; Liu Y; Wu L; He X
    Hum Pathol; 2018 Nov; 81():113-120. PubMed ID: 30136646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Decreased expression of TRIM3 is associated with poor prognosis in patients with primary hepatocellular carcinoma.
    Chao J; Zhang XF; Pan QZ; Zhao JJ; Jiang SS; Wang Y; Zhang JH; Xia JC
    Med Oncol; 2014 Aug; 31(8):102. PubMed ID: 24994609
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The circular RNA ciRS-7 (Cdr1as) acts as a risk factor of hepatic microvascular invasion in hepatocellular carcinoma.
    Xu L; Zhang M; Zheng X; Yi P; Lan C; Xu M
    J Cancer Res Clin Oncol; 2017 Jan; 143(1):17-27. PubMed ID: 27614453
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated ZC3H15 increases HCC growth and predicts poor survival after surgical resection.
    Jiang BG; Wan ZH; Huang J; Li LM; Liu H; Fu SY; Yang Y; Zhang J; Yuan SX; Wang RY; Yang Y; Gu FM; Dong LW; Pan ZY; Zhou WP
    Oncotarget; 2016 Jun; 7(24):37238-37249. PubMed ID: 27191988
    [TBL] [Abstract][Full Text] [Related]  

  • 19. DEP domain containing 1 is a novel diagnostic marker and prognostic predictor for hepatocellular carcinoma.
    Yuan SG; Liao WJ; Yang JJ; Huang GJ; Huang ZQ
    Asian Pac J Cancer Prev; 2014; 15(24):10917-22. PubMed ID: 25605201
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Importance of SALL4 in the development and prognosis of hepatocellular carcinoma.
    Yin F; Han X; Yao SK; Wang XL; Yang HC
    World J Gastroenterol; 2016 Mar; 22(9):2837-43. PubMed ID: 26973422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.